Javascript must be enabled to continue!
Impact of inhalation therapy on occurrence of oral manifestations in patients with bronchial asthma, in Jeddah, Saudi Arabia
View through CrossRef
Background: Inhalation therapy for asthma includes cortisol and bronchodilators. High dosage and long duration of inhalation therapy has been linked with several adverse effects on the oral tissues. Objectives: To explore the oral manifestations associated with the use of inhalation therapy among patients with asthma in Jeddah city. Method: This was a cross sectional study; the non-probability convenient sampling method was used to select 215 subjects (99 with Doctor diagnosed asthma and 116 without asthma), from the outpatient clinics of two private hospitals. Data were collected using interview questionnaire, the standard 5th ed. WHO survey on oral manifestations, measurement of vital signs and anthropometric parameters, as well as clinical oral examination. Data were analyzed using SPSS version 22, and Logistic multinomial regression was used to study the Odds ratio and its 95% confidence interval between the variables. Level of significance for the study was 0.05. Results: The majority of patients with asthma (95%) used inhalation therapy, without use of spacers. Ulceration, pigmentation and candidiasis of the tongue, buccal mucosa and palate weresignificantly more encountered among patients with asthma compared to those without asthma (p < 0.001, 0.002 and 0.046 respectively). Xerostomia and salivary gland affection, also, were significantly more encountered among patients with asthma compared to those without asthma (p < 0.000, and 0.002 respectively). Patients with asthma were 7.7 times more likely to develop tongue disorders (OR: 7.7, p < 0.013), 3 times more likely to develop buccal mucosal disorders (OR: 3, p < 0.039), and 15 times more likely to develop palate disorders (OR: 15, p < 0.004) compared to subjects without bronchial asthma. Conclusion: Use of inhalation therapy in patients with asthma was significantly associated with increased occurrence of oral health problems. Health education programs about proper use of inhalers and oral hygiene should be implemented by primary health care personnel. Key words: Inhalation therapy, Asthma, Oral manifestations, Jeddah.
Title: Impact of inhalation therapy on occurrence of oral manifestations in patients with bronchial asthma, in Jeddah, Saudi Arabia
Description:
Background: Inhalation therapy for asthma includes cortisol and bronchodilators.
High dosage and long duration of inhalation therapy has been linked with several adverse effects on the oral tissues.
Objectives: To explore the oral manifestations associated with the use of inhalation therapy among patients with asthma in Jeddah city.
Method: This was a cross sectional study; the non-probability convenient sampling method was used to select 215 subjects (99 with Doctor diagnosed asthma and 116 without asthma), from the outpatient clinics of two private hospitals.
Data were collected using interview questionnaire, the standard 5th ed.
WHO survey on oral manifestations, measurement of vital signs and anthropometric parameters, as well as clinical oral examination.
Data were analyzed using SPSS version 22, and Logistic multinomial regression was used to study the Odds ratio and its 95% confidence interval between the variables.
Level of significance for the study was 0.
05.
Results: The majority of patients with asthma (95%) used inhalation therapy, without use of spacers.
Ulceration, pigmentation and candidiasis of the tongue, buccal mucosa and palate weresignificantly more encountered among patients with asthma compared to those without asthma (p < 0.
001, 0.
002 and 0.
046 respectively).
Xerostomia and salivary gland affection, also, were significantly more encountered among patients with asthma compared to those without asthma (p < 0.
000, and 0.
002 respectively).
Patients with asthma were 7.
7 times more likely to develop tongue disorders (OR: 7.
7, p < 0.
013), 3 times more likely to develop buccal mucosal disorders (OR: 3, p < 0.
039), and 15 times more likely to develop palate disorders (OR: 15, p < 0.
004) compared to subjects without bronchial asthma.
Conclusion: Use of inhalation therapy in patients with asthma was significantly associated with increased occurrence of oral health problems.
Health education programs about proper use of inhalers and oral hygiene should be implemented by primary health care personnel.
Key words: Inhalation therapy, Asthma, Oral manifestations, Jeddah.
Related Results
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Exercise in Children with Bronchial Asthma: A Non-Pharmacological Adjunct to Bronchial Asthma Management
Exercise in Children with Bronchial Asthma: A Non-Pharmacological Adjunct to Bronchial Asthma Management
Exercise in a child with bronchial asthma is a significant subject of interest to the child, physician and parents. Most children with asthma would like to engage in sports. Howeve...
Prevalence of bronchial asthma and its impact on secondary school students in Al Majardah governorate, Aseer region, Saudi Arabia
Prevalence of bronchial asthma and its impact on secondary school students in Al Majardah governorate, Aseer region, Saudi Arabia
Bronchial asthma is a major public health problem. The Saudi Initiative for Asthma (2012) reported that the prevalence of asthma in Saudi adults is not well known, but the overall ...
Health locus of control related daily living activities during COVID 19 pandemic as an indicator of Bronchial Asthma
Health locus of control related daily living activities during COVID 19 pandemic as an indicator of Bronchial Asthma
Background: Bronchial asthma is a widespread chronic airway inflammatory disease, and it is characterized by paroxysmal or continual respiratory manifestations and airway airflow l...
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
Background/objectives: The association between adverse childhood experiences (ACEs) and asthma severity among United States (US) adults with asthma has not been well documented. In...
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
Asthma, a ubiquitous chronic respiratory ailment, stands as a formidable global health concern, affecting millions of individuals across the world. This widespread condition, marke...
Management of Patients with Bronchial Asthma: GINA 2021
Management of Patients with Bronchial Asthma: GINA 2021
Бронхиальная астма является широко распространенным гетерогенным заболеванием легких, характеризующимся хроническим воспалением дыхательных путей, наличием изменяющихся по времени ...

